Clinical Analyzer Market to Undertake Strapping Growth by 2021

Clinical analyzer is a laboratory instrument used to analyze the concentration of analytes such as metabolites, proteins, electrolytes, and drugs in serum and plasma sample. It is also used to analyze blood components including white blood cells and red blood cells. It helps in diagnosis of various diseases such as cancer, HIV, diabetes, hepatitis, and kidney disorders. Various measurement technological methods including colorimetric testing, photometric testing, latex agglutination, and ion-selective potentiometry are used to analyze samples of blood serum, urine, and plasma. Photometric testing is the most common method used for verifying intensity through clinical analyzer. It uses sample mixed with a reagent for the production of color reaction and to further determine the concentration of volume that passes through photometer.

A sample of this report is available upon request @ www.persistencemarketresearch.com/samples/4404

Colorimetric testing is a method used to determine the presence of any chemical substance in a sample with the help of a color reagent. Latex agglutination is a method for testing antibodies or antigens inside bodily fluids such as saliva, urine, blood, and cerebrospinal fluids. This test is used to identify various infectious diseases. In addition, ion-selective potentiometry is used to measure the concentration of ions such as Li+, Na+, and K+. The two forms of clinical chemical analyzers observed in the market are analyzers using standard clinical chemistry and analyzers using integrating clinical chemistry analysis. Clinical analyzers are used in small point-of-care clinics and high-throughput clinical labs.

Currently, North America dominates the global clinical analyzer market, followed by Europe. This is due to the rising prevalence of infectious and non-infectious diseases and increasing demand for laboratory automation in the clinical laboratories in these regions. In addition, increase in the number of healthcare insurance holders, especially in the U.S., is also influencing the growth of the clinical analyzer market. Asia is expected to be the fastest growing market in the next five years. This is due to the rising health care infrastructure and increasing government initiatives for better health care facilities in this region. Moreover, presence of a large patient population base is also driving the growth of the clinical analyzer market in the region.

Rising aging population, increasing number of reagent rental agreements, and rising number of lifestyle associated disorders are some of the key factors driving the growth of the global clinical analyzer market. In addition, factors such as the rising per capita income in developing countries and increasing health care awareness are also driving the growth of the global clinical analyzer market. However, high capital requirement and the stringent regulatory policies imposed by the various governments for medical devices are restraining the growth of the global clinical analyzer market. The high cost of clinical analyzers also impedes their market growth.

Technological advancements in automation systems, including hardware and software, and availability of cost-effective analyzers could create opportunities for new players in the global clinical analyzer market. In addition, emerging markets such as India and China could also create new opportunities for new entrants in the market. However, increasing number of consolidations in the market could restrain the entry of new players in the market. Moreover, maintaining accuracy and quality of clinical analyzers could pose a challenge for the growth of the global clinical analyzer market. Increasing demand for high throughput clinical analyzers and modular automated analyzers and rising number of product innovations are some of the recent trends witnessed in the global clinical analyzer market.

To view TOC of this report is available upon request @ www.persistencemarketresearch.com/toc/4404

The major companies operating in this market are Abbott Laboratories, Randox Laboratories Ltd., Thermo Fisher Scientifc Inc., Siemens AG, Danaher Corporation, Mindray Medical International Limited, and ELITechGroup.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

This release was published on openPR.